About this trial
The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).
Eligibility criteria
Qualifiers
Patients ≥ 18 years old
Informed consent
Scheduled for periacetabular osteotomy under general anesthesia with intubation
American Society of Anesthesiologists (ASA) physical status classification I to III
Disqualifiers
Known allergy to ropivacaine
Daily use of opioids, gabapentin or tricyclic antidepressant (regardless of dose) within the last four weeks prior to surgery
Contraindications to Celocoxib, NSAIDs or paracetamol
Trial design
Treatments tested in this trial
- Ropivacaine 5mg/ml 20ml
- Saline 0.9%
Treatment groups
Sponsors and collaborators
Matias Vested
Lead sponsor
Rigshospitalet, Denmark
Sponsor institution